Neuroprotection against ischemic brain injury by knockdown of hematopietic progenitor kinase 1 expression

Neuroreport. 2008 Apr 16;19(6):647-51. doi: 10.1097/WNR.0b013e3282f942a8.

Abstract

In this study, we investigated the role of hematopietic progenitor kinase 1 (HPK1) in delayed neuronal damage after cerebral ischemia and the possible regulatory mechanisms of this event. Our data show that tyrosine phosphorylation of HPK1 was significantly increased at 6 h of ischemic-reperfusion compared with sham control. The increase in p-HPK1, p-MLK3, p-MKK7, and p-JNK3 was attenuated by HPK1 antisense oligodeoxynucleotides intra-cerebroventricular infusion, but not MS-ODNs or vehicle. Intracerebroventricular infusion of antisense oligodeoxynucleotides also increased the number of surviving pyramidal neurons, whereas MS-ODNs or vehicle (TE) groups had no effects. These results indicate that knockdown of HPK1 expression provides neuroprotection through downregulation activation of the MLK3-MKK7-JNK3 pathway following cerebral ischemia in the rat hippocampus CA1 subfield.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Brain / metabolism*
  • Enzyme Activation / physiology
  • Hypoxia-Ischemia, Brain / metabolism*
  • Immunoprecipitation
  • MAP Kinase Kinase 7 / metabolism
  • MAP Kinase Kinase Kinases / metabolism
  • Male
  • Mitogen-Activated Protein Kinase 10 / metabolism
  • Mitogen-Activated Protein Kinase Kinase Kinase 11
  • Nerve Degeneration / metabolism*
  • Oligodeoxyribonucleotides, Antisense
  • Phosphorylation
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Protein Serine-Threonine Kinases / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / physiology*

Substances

  • Oligodeoxyribonucleotides, Antisense
  • Mitogen-Activated Protein Kinase 10
  • hematopoietic progenitor kinase 1
  • Protein Serine-Threonine Kinases
  • MAP Kinase Kinase Kinases
  • MAP Kinase Kinase 7